Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Cardiff Oncology, Inc. (CRDF) had Operating Cash Flow per Share of $-0.48 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.12M |
|
$-11.26M |
|
-- |
|
$0.12M |
|
$12.09M |
|
$-11.97M |
|
$0.72M |
|
$-11.26M |
|
$-11.26M |
|
$-11.26M |
|
$-11.26M |
|
$-11.26M |
|
$-11.26M |
|
$-11.97M |
|
$-12.14M |
|
66.88M |
|
66.88M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$61.80M |
|
$0.67M |
|
$1.98M |
|
$63.78M |
|
$14.71M |
|
-- |
|
$0.28M |
|
$14.99M |
|
$48.79M |
|
$48.79M |
|
$48.79M |
|
67.09M |
|
| Cash Flow Statement Financials | |
$-31.96M |
|
$-9.41M |
|
$0.03M |
|
$51.47M |
|
$10.13M |
|
$-41.34M |
|
$4.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-9978.33% |
|
-9978.33% |
|
-- |
|
-9381.67% |
|
-9386.67% |
|
$-32.00M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.47 |
|
190.50 |
|
-23.07% |
|
-23.07% |
|
-17.65% |
|
-23.07% |
|
$0.73 |
|
$-0.48 |
|
|
Operating Cash Flow per Share |
$-0.48 |